MiR-221/SIRT1/Nrf2 Signal Axis Regulates High Glucose Induced Apoptosis in Human Retinal Microvascular Endothelial Cells
Overview
Authors
Affiliations
Background: Diabetic retinopathy (DR) is a serious symptom associated with diabetes and could cause much suffer to patients. MiR-221, SIRT1 and Nrf2 were associated with apoptosis and proliferation and their expression were altered in DR patients. However, their roles and regulatory mechanisms in human retinal microvascular endothelial cells (hRMEC) were not clear.
Methods: Expression of mRNA was detected by qRT-PCR. Protein expression was detected by Western blot. Interaction between miR-221 and SIRT1 was predicted by bioinformatics analysis and validated by dual-luciferase reporter assay. We analyzed the viability and apoptosis of hRMEC by MTT assay and FACS assay, respectively.
Results: High glucose (HG) treatment enhanced expression of miR-221 and inhibited expression of SIRT1 and Nrf2. MiR-221 overexpression promoted apoptosis under HG condition. Moreover, miR-221 directly interacted with mRNA of SIRT1 and inhibited SIRT1 expression in hRMEC, through which miR-221 inhibited Nrf2 pathway and induced apoptosis of hRMEC.
Conclusion: Our data demonstrated that miR-221/SIRT1/Nrf2 signal axis could promote apoptosis in hRMEC under HG conditions. This finding could provide theoretical support for future studies and may contribute to development of new treatment options to retard the process of DR development.
From Microcirculation to Aging-Related Diseases: A Focus on Endothelial SIRT1.
Law M, Wang P, Zhou Z, Wang Y Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598406 PMC: 11597311. DOI: 10.3390/ph17111495.
Wu Q, Liu C, Shu X, Duan L Cell Biol Toxicol. 2024; 40(1):53.
PMID: 38970639 PMC: 11227466. DOI: 10.1007/s10565-024-09896-z.
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions.
Caruso L, Fields M, Rimondi E, Zauli G, Longo G, Marcuzzi A Int J Mol Sci. 2024; 25(4).
PMID: 38396799 PMC: 10889839. DOI: 10.3390/ijms25042124.
Dysregulation of histone deacetylases in ocular diseases.
Jun J, Kim J, Palomera L, Jo D Arch Pharm Res. 2023; 47(1):20-39.
PMID: 38151648 DOI: 10.1007/s12272-023-01482-x.
Research progress on the pathogenesis of diabetic retinopathy.
Li H, Liu X, Zhong H, Fang J, Li X, Shi R BMC Ophthalmol. 2023; 23(1):372.
PMID: 37697295 PMC: 10494348. DOI: 10.1186/s12886-023-03118-6.